Nuzenio

Studies Pr Newswire

Studies Pr Newswire entity intelligence is not indexable yet because Nuzenio needs more live source-attributed coverage.

topic 5 latest news signals 1 publisher sources 100/100 entity strength

Latest news

S&C Electric Company and Argonne National Laboratory Expand Research to Turn Scientific Discovery into Grid Solutions - PR NewswirePR Newswire · Mon, 10 Aug 2026 14:07:00 GMTIndependent MUSC Research Demonstrates Enterprise Value of AI-Native Virtual Nursing Powered by ThinkAndor® - PR NewswirePR Newswire · Mon, 10 Aug 2026 13:30:00 GMTFlorida Cancer Specialists & Research Institute Welcomes Neel K. Gakhar, MD - PR NewswirePR Newswire · Mon, 10 Aug 2026 13:24:00 GMTOmniActive's Zenroot, Root-Only Ashwagandha Extract Is Now USP Verified - PR NewswirePR Newswire · Mon, 10 Aug 2026 12:34:00 GMTAscletis Announces Initiation of Two Phase I Studies in U.S. for the Treatment of Obesity: ASC36 Once-Monthly Injection, an Amylin Receptor Peptide Agonist, and ASC36_35FDC Once-Monthly Injection, a Co-Formulation of ASC36 and GLP-1R/GIPR Peptide - PR NewswirePR Newswire · Mon, 10 Aug 2026 11:00:00 GMTPolymarket Launches Institute to Advance the Science of Prediction Markets - PR NewswirePR Newswire · Wed, 29 Jul 2026 07:00:00 GMT

Timeline

Mon, 10 Aug 2026 14:07:00 GMTS&C Electric Company and Argonne National Laboratory Expand Research to Turn Scientific Discovery into Grid Solutions - PR Newswire
Mon, 10 Aug 2026 13:30:00 GMTIndependent MUSC Research Demonstrates Enterprise Value of AI-Native Virtual Nursing Powered by ThinkAndor® - PR Newswire
Mon, 10 Aug 2026 13:24:00 GMTFlorida Cancer Specialists & Research Institute Welcomes Neel K. Gakhar, MD - PR Newswire
Mon, 10 Aug 2026 12:34:00 GMTOmniActive's Zenroot, Root-Only Ashwagandha Extract Is Now USP Verified - PR Newswire
Mon, 10 Aug 2026 11:00:00 GMTAscletis Announces Initiation of Two Phase I Studies in U.S. for the Treatment of Obesity: ASC36 Once-Monthly Injection, an Amylin Receptor Peptide Agonist, and ASC36_35FDC Once-Monthly Injection, a Co-Formulation of ASC36 and GLP-1R/GIPR Peptide - PR Newswire
Wed, 29 Jul 2026 07:00:00 GMTPolymarket Launches Institute to Advance the Science of Prediction Markets - PR Newswire

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Studies Pr Newswire.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

1 distinct publisher/source names are currently connected to this entity page.